The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis
- PMID: 16385194
- DOI: 10.1097/01.mou.0000193365.46081.cd
The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis
Abstract
Purpose of review: To investigate the relationship, diagnosis and treatment of the overlapping lower urinary tract symptoms experienced by men diagnosed with benign prostatic hyperplasia and prostatitis.
Recent findings: Recent studies have clearly shown that men can suffer from both benign prostatic hyperplasia and prostatitis. Approximately 5-20% of men diagnosed with benign prostatic hyperplasia suffer from prostatitis-like symptoms, while over one third of men diagnosed with benign prostatic hyperplasia have had a diagnosis of prostatitis in the past. Differentiation between these two symptom-based medical conditions can be difficult because of overlapping symptoms, but pain clearly identifies those patients with chronic prostatitis. Treatment for men with co-occurring benign prostatic hyperplasia and prostatitis may include alpha-blockers, 5alpha-reductase inhibitors and phytotherapies (saw palmetto and bee pollen extract), with evidence clearly showing the benefits of alpha-blocker therapy.
Summary: Benign prostatic hyperplasia and chronic prostatitis are a common cause of lower urinary tract symptoms and frequently co-occur in older men. The best treatment for men with lower urinary tract symptoms associated with both benign prostatic hyperplasia and prostatitis is alpha-blockers.
Similar articles
-
Benign Prostatic Hyperplasia.Prim Care. 2019 Jun;46(2):223-232. doi: 10.1016/j.pop.2019.02.003. Epub 2019 Apr 1. Prim Care. 2019. PMID: 31030823 Review.
-
Chronic inflammation in benign prostatic hyperplasia: Pathophysiology and treatment options.Int J Urol. 2024 Sep;31(9):968-974. doi: 10.1111/iju.15518. Epub 2024 Jun 27. Int J Urol. 2024. PMID: 38934050 Free PMC article. Review.
-
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.BJU Int. 2005 Mar;95(4):571-4. doi: 10.1111/j.1464-410X.2005.05341.x. BJU Int. 2005. PMID: 15705082
-
Chronic prostatitis: management strategies.Drugs. 2009;69(1):71-84. doi: 10.2165/00003495-200969010-00005. Drugs. 2009. PMID: 19192937 Review.
-
[Referral criteria for benign prostatic hyperplasia in primary care.Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina General, Sociedad Española de Medicina de Familia y Comunitaria, Asociación Española de Urología].Actas Urol Esp. 2010 Jan;34(1):24-34. doi: 10.1016/s0210-4806(10)70007-3. Actas Urol Esp. 2010. PMID: 20223130 Spanish.
Cited by
-
α-Blockers for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Update on Current Clinical Evidence.Rev Urol. 2012;14(3-4):56-64. Rev Urol. 2012. PMID: 23526487 Free PMC article.
-
Efficacy of acupuncture for chronic prostatitis/chronic pelvic pain syndromes: study protocol for a randomized, sham acupuncture-controlled trial.BMC Complement Altern Med. 2016 Nov 7;16(1):440. doi: 10.1186/s12906-016-1428-y. BMC Complement Altern Med. 2016. PMID: 27821109 Free PMC article. Clinical Trial.
-
Urethral dysfunction in a rat model of chemically induced prostatic inflammation: potential involvement of the MRP5 pump.Am J Physiol Renal Physiol. 2020 Mar 1;318(3):F754-F762. doi: 10.1152/ajprenal.00566.2019. Epub 2020 Feb 10. Am J Physiol Renal Physiol. 2020. PMID: 32036697 Free PMC article.
-
Diagnosis and management of benign prostatic hyperplasia in primary care.Can Urol Assoc J. 2009 Jun;3(3 Suppl 2):S92-S100. doi: 10.5489/cuaj.1116. Can Urol Assoc J. 2009. PMID: 19543429 Free PMC article.
-
ZapA, a virulence factor in a rat model of Proteus mirabilis-induced acute and chronic prostatitis.Infect Immun. 2008 Nov;76(11):4859-64. doi: 10.1128/IAI.00122-08. Epub 2008 Aug 25. Infect Immun. 2008. PMID: 18725420 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous